MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17
Frontiers in Bioscience-Landmark · 23.01.2024 · 29 (1)
DOI: 10.31083/j.fbl2901044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 23.01.2024. Verfasst von Yingying Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jieyang Medical Research Center, Jieyang People's Hospital, 522000 Jieyang, Guangdong, China. Hauptthemen laut MEDLINE: ADAM17 Protein, MicroRNAs, Sepsis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Scientific Research Foundation of Guangdong Province, Science and Technology Innovation Leading talents Project of Jieyang City, Natural Science Foundation of Guangdong Province.
Themen: Sepsis
Abstract (Originalsprache)
Background
Current studies have demonstrated that disintegrin and metalloproteinase 17 (ADAM17) plays a critical role in the pathogenesis of sepsis. MicroRNA (miR)-145 is known to control immune responses as an anti-inflammatory modulatory molecule. However, a fundamental understanding of how miR-145 regulates ADAM17 and, more broadly, sepsis-induced inflammatory response remains unknown.
Methods
We used western blotting and quantitative real-time PCR (qRT-PCR) to measure expression levels of ADAM17 and miR-145. Enzyme-linked immunosorbent assays (ELISA) were performed to measure cytokine production. To determine if ADAM17 is a target gene of miR-145, bioinformatics analyses and luciferase reporter assays were conducted. The impacts of ADAM17 and miR-145 on sepsis-induced inflammatory responses were accessed in vitro using human umbilical endothelial cells (HUVECs) treated with lipopolysaccharide (LPS). Sepsis-induced inflammatory response was measured in vivo using a polymicrobial septic mouse model induced by cecal ligation and puncture (CLP) with pre-injection of a miR-145 agomir.
Results
In HUVECs treated with LPS, miR-145 expression was downregulated and miR-145 negatively regulated ADAM17 expression through direct binding to the ADAM17 transcript 3′-UTR. MiR-145 overexpression markedly reduced LPS-induced inflammatory cytokine production by targeting ADAM17 in HUVECs. In comparison to CLP-induced septic mice treated with a control agomir, treatment with a miR-145 agomir significantly reduced the expression of ADAM17, numerous downstream cytokines such as IL-6, TNF-α, IL-1β and MCP-1, and the endothelial injury factors ICAM-1, VCAM-1. The miR-145 agomir also alleviated acute lung and kidney injury and improved the survival rate of septic mice.
Conclusions
This study showed that miR-145, by specifically targeting ADAM17, negatively regulates sepsis-induced inflammatory responses and vascular endothelial injury, and ultimately improved organ injury and survival during sepsis. The underlying mechanism for the regulation of ADAM17 expression by miR-145 and sepsis-induced inflammatory reactions may offer sepsis patients a novel therapeutic option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jieyang Medical Research Center, Jieyang People's Hospital, 522000 Jieyang, Guangdong, China.
- The Intensive Care Unit, Affiliated Hospital of Guangdong Medical University, 524002 Zhanjiang, Guangdong, China.
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.
- NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, 510080 Guangzhou, Guangdong, China.
Förderung
- Medical Scientific Research Foundation of Guangdong Province
- Science and Technology Innovation Leading talents Project of Jieyang City
- Natural Science Foundation of Guangdong Province
- Science and Technology Project of Jieyang City
Zitieren
APA
Lin, Y., Liu, L., Lin, Y., Yang, R., Liao, S., Xu, M., He, J., & Liu, Q. (2024). MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17. Frontiers in Bioscience-Landmark, 29(1). https://doi.org/10.31083/j.fbl2901044
Vancouver
Lin Y, Liu L, Lin Y, Yang R, Liao S, Xu M, et al. MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17. Frontiers in Bioscience-Landmark. 2024;29(1). doi:10.31083/j.fbl2901044
BibTeX
@article{Lin2024,
author = {Lin, Yingying and Liu, Lizhen and Lin, Yao and Yang, Ruoxuan and Liao, Shuanglin and Xu, Mingwei and He, Junbing and Liu, Qinghua},
title = {MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
volume = {29},
number = {1},
doi = {10.31083/j.fbl2901044}
}
EUVIMED